https://www.selleckchem.com/products/gdc-0068.html
The purpose of this review is to show the imaging findings in PGO, with special emphasis on the US appearance. Mitoxantrone (MTX) is a synthetic compound used as a second line chemotherapeutic drug for prostate cancer. It has been reported to trigger immunogenic cell death (ICD) in animal model studies, but the underlying mechanism is not fully understood yet, especially not in prostate cancer cells. ICD was determined by assessing the release of damage-associated molecular patterns (DAMPs) in the prostate cancer-derived cell lines LNC
Like
Comment
Share
